×
About 868 results

ALLMedicine™ Hallucinogens Center

Research & Reviews  284 results

A century of research on psychedelics: A scientometric analysis on trends and knowledge...
https://doi.org/10.1016/j.euroneuro.2022.09.004
European Neuropsychopharmacology : the Journal of the Eur... Solmi M, Chen C et. al.

Oct 4th, 2022 - A scientometric analysis was realized to outline clinical research on psychedelics over the last century. Web of Science Core Collection was searched up to March 18, 2022, for publications on psychedelics. Network analyses and bibliometrics were c...

Genetic Instability among Hitnü People Living in Colombian Crude-Oil Exploitation Areas.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517229
International Journal of Environmental Research and Publi... Galeano-Páez C, Ricardo-Caldera D et. al.

Sep 24th, 2022 - Oil exploitation, drilling, transportation, and processing in refineries produces a complex mixture of chemical compounds, including polycyclic aromatic hydrocarbons (PAHs), which may affect the health of populations living in the zone of influenc...

Contrasting effects of DOI and lisuride on impulsive decision-making in delay discounti...
https://doi.org/10.1007/s00213-022-06229-y
Psychopharmacology Jiang K, Liu X et. al.

Sep 16th, 2022 - The 5-HT2A receptor is the major target of classic hallucinogens. Both DOI (2,5-dimethoxy-4-iodoamphetamine) and lisuride act at 5-HT2A receptors, and lisuride shares comparable affinity with DOI and acts as a partial agonist at 5-HT2A receptors. ...

Toward a typology of driving under the influence of alcohol and drugs.
https://doi.org/10.1007/s00127-022-02342-7
Social Psychiatry and Psychiatric Epidemiology; Goings TC, Salas-Wright C et. al.

Sep 11th, 2022 - Most research on driving under the influence (DUI) has relied upon variable-centered methods that examine predictors/correlates of DUI. In the present study, we utilize a person-level approach-latent class analysis (LCA)-to model a typology of ind...

From neuroplasticity to psychoplasticity: Psilocybin may reverse personality disorders and political fanaticism
https://www.mdedge.com/psychiatry/article/257347/personality-disorders/neuroplasticity-psychoplasticity-psilocybin-may
Henry A. Nasrallah, MD

Sep 1st, 2022 - One of psychiatry’s long-standing dogmas is that personality disorders are enduring, unchangeable, and not amenable to treatment with potent psychotropics or intensive psychotherapy. I propose that this dogma may soon be shattered.

see more →

Clinicaltrials.gov  12 results

Psilocybin-facilitated Treatment for Chronic Pain
https://clinicaltrials.gov/ct2/show/NCT05068791

Aug 26th, 2022 - Participants will be randomized to two groups: Psilocybin or Active Placebo. Those in the Psilocybin condition will receive .36 mg/kg of psilocybin. Based on previous research, .36 mg/kg of psilocybin is expected to balance the intention to increa...

Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
https://clinicaltrials.gov/ct2/show/NCT01943994

Aug 4th, 2022 - One of the most promising lines of investigation for the therapeutic use of hallucinogens in the 1960s and 1970s was in the treatment of drug dependence. The investigators propose to examine psilocybin administration combined with a structured smo...

LSD Therapy for Persons Suffering From Major Depression
https://clinicaltrials.gov/ct2/show/NCT03866252

May 25th, 2022 - Background: Major Depressive Disorder is one of the most prevalent mental illnesses, leading to substantial personal distress and economical consequences. Pharmacological Treatment is limited and relapse is frequent. Lysergic acid diethylamide (LS...

Comparative Acute Effects of LSD, Psilocybin and Mescaline
https://clinicaltrials.gov/ct2/show/NCT04227756

Mar 31st, 2022 - LSD (lysergic acid diethylamide), psilocybin (the active substance in "magic mushrooms") and mescaline (the active substance in Peyote and San Pedro cacti) are serotonergic hallucinogens widely used for recreational and/or ethnomedical purposes. L...

LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders
https://clinicaltrials.gov/ct2/show/NCT03153579

Dec 22nd, 2021 - Background: Lysergic acid diethylamide (LSD) was extensively investigated in humans in the 1950s and 1960s. Particularly, LSD attenuated anxiety in patients with cancer. Clinical research with LSD ended in the 1970s due to regulatory restrictions ...

see more →

News  51 results

From neuroplasticity to psychoplasticity: Psilocybin may reverse personality disorders and political fanaticism
https://www.mdedge.com/psychiatry/article/257347/personality-disorders/neuroplasticity-psychoplasticity-psilocybin-may
Henry A. Nasrallah, MD

Sep 1st, 2022 - One of psychiatry’s long-standing dogmas is that personality disorders are enduring, unchangeable, and not amenable to treatment with potent psychotropics or intensive psychotherapy. I propose that this dogma may soon be shattered.

What Ketamine and Psilocybin Can and Cannot Do in Depression
https://www.medscape.com/viewarticle/979294

Aug 16th, 2022 - Recent studies with hallucinogens have raised hopes for an effective drug-based therapy to treat chronic depression. At the German Congress of Psychosomatic Medicine and Psychotherapy, Torsten Passie, MD, PhD, professor of psychiatry and psychothe...

A Pandemic Silver Lining? Dramatic Drop in Teen Drug Use
https://www.medscape.com/viewarticle/964881

Dec 15th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Illicit drug use among US teenagers dropped sharply in 2021 likely because of stay-at-home orders and other restrictions on social activities due ...

Marijuana and Hallucinogen Use on the Rise in Young People
https://www.medscape.com/viewarticle/959888

Sep 28th, 2021 - Young adults appear to be turning away from alcohol and toward marijuana and hallucinogens, according to a survey on national drug use trends. What to know: In 2020, marijuana use continued its recent increase among young adults. Hallucinogens lik...

Marijuana and LSD guidance for pediatricians
https://www.mdedge.com/pediatrics/article/246221/adolescent-medicine/marijuana-and-lsd-guidance-pediatricians
Susan D. Swick, MD, Michael S. Jellinek, MD

Sep 17th, 2021 - Seeking novelty is central to adolescence; experimentation is how they explore their identity, exert independence, and establish deep and connected relationships outside of the family. Research over the past 2 decades has demonstrated the neurobio.

see more →